Review



apc labeled anti human her3  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    R&D Systems apc labeled anti human her3
    Evaluation of afatinib sensitivity with Her2 or <t> Her3 </t> mutation
    Apc Labeled Anti Human Her3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/apc labeled anti human her3/product/R&D Systems
    Average 90 stars, based on 3 article reviews
    apc labeled anti human her3 - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer"

    Article Title: Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer

    Journal: Bladder Cancer (Amsterdam, Netherlands)

    doi: 10.3233/BLC-170144

    Evaluation of afatinib sensitivity with Her2 or Her3 mutation
    Figure Legend Snippet: Evaluation of afatinib sensitivity with Her2 or Her3 mutation

    Techniques Used: Mutagenesis



    Similar Products

    apc labeled anti human her3  (R&D Systems)
    90
    R&D Systems apc labeled anti human her3
    Evaluation of afatinib sensitivity with Her2 or <t> Her3 </t> mutation
    Apc Labeled Anti Human Her3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/apc labeled anti human her3/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    apc labeled anti human her3 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Evaluation of afatinib sensitivity with Her2 or Her3 mutation

    Journal: Bladder Cancer (Amsterdam, Netherlands)

    Article Title: Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer

    doi: 10.3233/BLC-170144

    Figure Lengend Snippet: Evaluation of afatinib sensitivity with Her2 or Her3 mutation

    Article Snippet: The following antibodies were used: Phycoerythrin or fluorescein isothiocyanate labeled rat monoclonal antibody to human EGFR (ICR 10, Abcam, Eugene, OR); allophycocyanin (APC) labeled anti-HER2 (Becton Dickinson Biosciences, San Jose, CA); APC labeled anti-human HER3 (R&D Systems, Minneapolis, MN); APC labeled anti-human HER4 (R&D Systems, Minneapolis, MN), and isotype controls mouse IgG2A (R&D Systems, Minneapolis, MN) and mouse IgG1 (Miltenyi Biotech, San Diego, CA).

    Techniques: Mutagenesis